ReviewFrontiers in pharmacology2026
Comprehensive review of tujia "Lian" medicinal botanical drugs: traditional classification system, phytochemical, and pharmacological profile.
Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tujia medicine categorizes drugs with similar effects into several major classes based on their ordinal numbers, primarily using the 36 and 72 ordinal number systems for organization. The drugs that mainly function to dispel wind and cold, promote blood circulation and disperse blood stasis, eliminate fire, dispel qi, relieve pain, and address dampness. Additionally, clearing the lymphatic system is collectively known as the "Seventy-Two Lian" method. This narrative review aims to provide a classification of "Seventy-Two Lian" and their attributions to alias, source, nature, flavor, and efficiency. It also summarizes the modern pharmacological effects of each species and its corresponding "Lian" drug. The goal is to provide a comprehensive overview of the current state of the Tujia "Lian" drugs and to promote further research and the use of these resources. The literature search for "Lian" drugs was conducted across various scientific databases, including SciFinder, Web of Science, Elsevier, PubMed, and CNKI, as well as ancient books and monographs. It collected the names, plant sources, and medicinal parts of "Lian" drugs from these sources, and identified the replaced Latin names in Chinese Plant Intelligence (https://www.iplant.cn). Relevant pharmacological studies were searched across various databases using Latin names and common names. The "Seventy-Two Lian" has a long history within Tujia ethnomedicine. Alongside its traditional uses, modern pharmacological effects have gained widespread attention. Recent studies have shown that "Lian" drugs generally exhibit a range of effects, including anti-inflammatory, analgesic, antibacterial, antioxidant, antitumor, antiviral, insecticidal, antidiabetic, neuroprotective, and hepatoprotective effects, as confirmed by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.